QQ客服 官方微博 反馈留言

	肿瘤标志物联合检测对肺癌诊断、病理分型和临床分期的临床价值 Clinical value of combined detection of tumor biomarkers in diagnosis, pathological typing and clinical staging in lung cancer＊
	陈一超[1]; 辇伟奇[1]; 冉静[1]; 何永鹏[1]; 王霞[1]; 易琳[1]
	2018
卷号	39页码:32-37
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3036255
专题	重庆大学
推荐引用方式 GB/T 7714	陈一超[1],辇伟奇[1],冉静[1],等. 肿瘤标志物联合检测对肺癌诊断、病理分型和临床分期的临床价值 Clinical value of combined detection of tumor biomarkers in diagnosis, pathological typing and clinical staging in lung cancer＊[J],2018,39:32-37.
APA	陈一超[1],辇伟奇[1],冉静[1],何永鹏[1],王霞[1],&易琳[1].(2018).肿瘤标志物联合检测对肺癌诊断、病理分型和临床分期的临床价值 Clinical value of combined detection of tumor biomarkers in diagnosis, pathological typing and clinical staging in lung cancer＊.,39,32-37.
MLA	陈一超[1],et al."肿瘤标志物联合检测对肺癌诊断、病理分型和临床分期的临床价值 Clinical value of combined detection of tumor biomarkers in diagnosis, pathological typing and clinical staging in lung cancer＊".39(2018):32-37.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。